AGENDA
SPEAKERS
SPONSORS
#BiologicsSummit2021
6th Annual
WEDNESDAY,
NOVEMBER 17, 2021
WELCOME
TO THE LOBBY
OUR PROGRAM WILL
BEGIN IN
Days
Hours
Minutes
Seconds
WELCOME VIDEO
AND INTERACT
#Biologics
Summit2021
EVENT
AGENDA
11:30 A.M. ET
Welcome
Speaker:
Josie Cooper,
Executive Director, Alliance for Patient Access
Session Info:
XXX
11:35 A.M. ET
Introduction
Speaker:
David Charles, MD,
Founder, Alliance for Patient Access, Co-Convener, Biologics Prescribers Collaborative
Session Info:
XXX
11:40 A.M. ET
Innovation and Rare Disease
Speakers:
Richard White,
Policy Analyst, National Organization for Rare Disorders
Layla Lohmann, DDS,
Rare Disease Advocate
David Charles, MD,
Founder, Alliance for Patient Access, Co-Convener, Biologics Prescribers Collaborative
Host: Josie Cooper,
Executive Director, Alliance for Patient Access
Session Info:
XXX
12:00 P.M. ET
Advocate's Perspective: Color of Crohn's
Speakers:
Melodie Narain-Blackwell,
Member, Color of Crohn's & Chronic Illness, Inc. Board of Directors
Host: Dennis Cryer, MD,
Co-Convener, Biologics Prescribers Collaborative
Session Info:
XXX
12:12 P.M. ET
Keynote
Speakers:
Sarah Yim, MD,
Director of the Office of Therapeutic Biologics and Biosimilars in FDA’s Center for Drug Evaluation and Research
Host: Gavin Clingham, JD,
Policy Director, Alliance for Patient Access
Session Info:
XXX
12:40 P.M. ET
Break
Session Info:
XXX
12:46 P.M. ET
Policy Brief: A Federal and State Legislative Update
Speakers:
Brian Henderson,
Director, State Government Affairs, Coalition of State Rheumatology Organizations
Angus Worthing, MD,
Member, American College of Rheumatology Board of Directors
Host: Gavin Clingham, JD,
Policy Director, Alliance for Patient Access
Session Info:
XXX
1:11 P.M. ET
Expanding Options: Biosimilars
Speakers:
Chad Pettit,
Executive Director, Marketing, Amgen
Karen McKerihan, MSN, NP-C,
Member, Rheumatology Nurses Society Board of Directors
Pam Traxel,
Senior Vice President, American Cancer Society Cancer Action Network
Host: Susan Hepworth,
Director of Media Affairs, Alliance for Patient Access
Session Info:
XXX
1:36 P.M. ET
Insulin Affordability and Interchangeables
Speakers:
Rob Goldsmith,
Director, Policy and Advocacy, Endocrine Society
Host: Susan Hepworth,
Director of Media Affairs, Alliance for Patient Access
Session Info:
XXX
1:53 P.M. ET
Closing Remarks
Speakers:
Rob Goldsmith,
Endocrine Society
Host: Dennis Cryer, MD,
Co-convener, Biologics Prescribers Collaborative
Session Info:
XXX
KEYNOTE
SPEAKER
Linkedin-in
SARAH YIM, MD
DIRECTOR,
OFFICE OF THERAPEUTIC BIOLOGICS AND BIOSILMILARS IN FDA’S CENTER FOR DRUG EVALUATION AND RESEARCH
FEATURED
SPEAKERS
DAVID CHARLES, MD
FOUNDER,
ALLIANCE FOR PATIENT ACCESS
CO-CONVENER,
BIOLOGICS PRESCRIBERS COLLABORATIVE
Linkedin-in
Twitter
GAVIN CLINGHAM, JD
POLICY DIRECTOR,
ALLIANCE FOR PATIENT ACCESS
Linkedin-in
Twitter
JOSIE COOPER
EXECUTIVE DIRECTOR,
ALLIANCE FOR PATIENT ACCESS
Linkedin-in
Twitter
DENNIS CRYER, MD
CO-CONVENER,
BIOLOGICS PRESCRIBERS COLLABORATIVE
Linkedin-in
Twitter
ROB GOLDSMITH
DIRECTOR, POLICY AND ADVOCACY,
ENDOCRINE SOCIETY
Linkedin-in
Twitter
BRIAN HENDERSON
DIRECTOR,
STATE GOVERNMENT AFFAIRS,
COALITION OF STATE RHEUMATOLOGY ORGANIZATIONS
Linkedin-in
Twitter
SUSAN HEPWORTH
DIRECTOR OF MEDIA AFFAIRS
ALLIANCE FOR PATIENT ACCESS
Linkedin-in
Twitter
LAYLA LOHMANN, DDS
RARE DISEASE ADVOCATE
Linkedin-in
KAREN MCKERIHAN,
MSN, NP-C
MEMBER,
RHEUMATOLOGY NURSES SOCIETY BOARD OF DIRECTORS
Linkedin-in
Twitter
MELODIE NARAIN-BLACKWELL
MEMBER,
COLOR OF CROHN'S AND CHRONIC ILLNESS, INC. BOARD OF DIRECTORS
Linkedin-in
CHAD PETTIT
EXECUTIVE DIRECTOR,
MARKETING,
AMGEN
Linkedin-in
Twitter
PAM TRAXEL
SENIOR VICE PRESIDENT,
AMERICAN CANCER SOCIETY CANCER ACTION NETWORK
Linkedin-in
RICHARD WHITE
POLICY ANALYST,
NATIONAL ORGANIZATION OF RARE DISORDERS
Linkedin-in
Twitter
ANGUS WORTHING, MD
MEMBER,
AMERICAN COLLEGE OF RHEUMATOLOGY BOARD OF DIRECTORS
Linkedin-in
Twitter
ANGUS WORTHING, MD
MEMBER,
AMERICAN COLLEGE OF RHEUMATOLOGY BOARD OF DIRECTORS
Linkedin-in
Twitter
CONVENED
BY:
CO-HOSTED
BY:
THANK YOU TO
OUR SPONSORS: